Phase 1 Study of CT-996 in Overweight/Obese Participants and Patients With Type 2 Diabetes Mellitus

NCT05814107 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

94

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes
Overweight or Obesity

Interventions

DRUG: CT-996
DRUG: Placebo

Sponsor

Carmot Australia First Pty Ltd

Collaborators

[object Object]
[object Object]